Lv11
50 积分 2024-10-26 加入
Improving therapeutic strategies for triple-negative breast cancer: synergistic effects of DKC1 inhibition and paclitaxel
2个月前
已完结
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial
3个月前
已完结
All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial
3个月前
已完结
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
3个月前
已完结
Application of machine learning techniques to the analysis and prediction of drug pharmacokinetics
5个月前
已完结
High-Throughput Methods for Combinatorial Drug Discovery
5个月前
已完结
Leveraging big data of immune checkpoint blockade response identifies novel potential targets
5个月前
已完结
Active Learning-Based Prediction of Drug Combination Efficacy
5个月前
已完结
Development, Characterization, and Therapeutic Utility of Paclitaxel‐Resistant Breast and Gastric Cancer In Vitro and In Vivo Models
5个月前
已完结
Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model
6个月前
已完结
皖公网安备34019202002308
